香港大學生物醫藥技術國家重點實驗室
State Key Laboratory of Pharmaceutical Biotechnology
The University of Hong Kong
Patents
-
Methods and compositions for use of neutrophil elastase and proteinase 3 as diagnostic biomarkers (WIPO (PCT) number: WO2015180687A1)
-
Methods and Compositions for use of Neutrophil Elastase and Proteinase 3 as Diagnostic Markers (US patent number: US9625460B2).
-
Non-polyaminated lcn2 as a biomarker for diagnosis and treatment of cardiometabolic diseases (WIPO (PCT) number: WO2018076284A1)
-
Inhibitors of fabp4 and methods of treating arthritis (WIPO (PCT) number: WO2018192469A1)
-
Lipocalin-2 antibodies for methods of treatments. (US patent number: 8,481,032B2)
-
Lipocalin-2 as a prognostic and diagnostic marker for heart and stroke risks. (US patent number: 8,030,097 B2)
-
Phosphoprotein target for insulin and insulin antagonists. (US patent number: US 6,884,575)
-
Adiponectin and uses thereof. (US patent Number: 7,365,170)
-
Lipocalin-2 as a diagnostic marker and therapeutic target. (US patent No: 7,645,616.)